Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Takeda’s TAK-279 meets primary endpoint in Phase 2b trial for psoriatic arthritis Takeda Pharmaceutical Company announced positive results from its Phase 2b clinical trial for TAK-279, an investigational oral TYK2… byPallavi MadhirajuSeptember 12, 2023